Ctt Pharmaceutical Holdings CTTH Insider Ownership

OTC CTTH
$0.06 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Insider Holdings by Owner

16.42Mn Shares
Pharmaceutical Holdings, Inc. Ctt16.42Mn100.0%

Insider Ownership Statistics

as of 31 Mar, 2016
Insider Ownership
47.23%
■0% pp QoQ
Shares Held by Insiders
10.07Mn
filed for Mar 2016
■0.00% QoQ
Shares Outstanding
59.72Mn
59,722,232 shares
Direct Holdings
10.07Mn
Indirect: 0
Net Open-Market Trades
0
no open-market trades in Mar 2016
Insiders Holding Shares
1
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Open-Market Insider Trades

Bought Sold
Latest quarter —
Net over range —
Net-buying quarters —

Insider Ownership Summary

Updated

Over the past year, CTTH insiders did not buy or sell the stock on the open market.

Form 4 Holdings

Insiders Holding CTTH

Insiders 1
Shares held 16.42Mn
Of outstanding 27.49%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Pharmaceutical Holdings, Inc. Ctt Ceo 16,419,392 0 16,419,392 100.0% 06 Nov, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

83 Insider Transactions

Source SEC Form 4
Latest quarter Mar 2016
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
04 Nov, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 9,000 $0.05 $450 9,452,536 Direct
15 Oct, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 2,000 $0.06 $114 9,436,656 Direct
06 Oct, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,700 $0.06 $204 9,433,656 Direct
22 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,100 $0.05 $455 9,424,556 Direct
28 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,400 $0.06 $187 9,429,956 Direct
22 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,100 $0.05 $455 1,056,800 Direct
16 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,900 $0.05 $523 9,414,456 Direct
10 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,500 $0.05 $175 9,400,556 Direct
04 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 9,800 $0.05 $479 9,397,056 Direct
02 Sep, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,000 $0.05 $147 9,387,256 Direct
31 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 3,500 $0.05 $172 9,384,256 Direct
24 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 2,100 $0.06 $116 9,360,756 Direct
20 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 11,500 $0.05 $518 9,378,656 Direct
19 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 10,000 $0.06 $590 9,365,456 Direct
14 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 1,800 $0.06 $112 9,355,456 Direct
07 Aug, 2026 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 7,700 $0.07 $501 9,353,656 Direct
17 Dec, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 8,300 $0.06 $457 7,845,956 Direct
20 Nov, 2025 Pharmaceutical Holdings, Inc. Ctt Director Acquired P 200,000 $0.04 $8.00K 3,734,003 Direct
20 Nov, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 62,900 $0.04 $2.52K 7,837,656 Direct
31 Oct, 2025 Pharmaceutical Holdings, Inc. Ctt Ceo Acquired P 7,000 $0.06 $420 7,774,756 Direct